IVD Raw Materials
Home » Sustainability
Adhering to the corporate mission to “Make People and Nature Healthier through Biotechnology”, GenScript integrates sustainability into strategic planning. While driving stable growth across our business portfolio, we also strive to improve our environmental, social and governance performance. Along with our global business partners, clients, suppliers and all other stakeholders, we aim to make a positive impact and give back to society.
EcoVadis Silver Medal
Global Top 15%
MSCI ESG AA Rating
Included in the S&P Global Sustainability Yearbook 2026
FTSE4Good Index Series
Sustainalytics ESG "Low Risk" Rating
CDP Climate Change B Rating
A signatory of the United Nations Global Compact (UNGC)
Decarbonization targets approved by the Science Based Targets Initiative (SBTi)
Pharmaceutical Supply Chain Initiative (PSCI) Supplier Partner
31% operational sites certified to ISO 14001
Our GHG reduction targets validated by SBTi:
83% suppliers with SBTi targets by 2029
54.6% reduction in Scope 1 & 2 emissions by 2033
Net-zero across Scope 1, 2 & 3 by 2050
58.7% female employees
49.6% women in managerial positions
100% employees with professional development training
91.1% employee retention
37 new patents granted
271 patents granted cumulatively
4,389 volunteer service hours
1,268 volunteer participations
100% employees and Board members trained on business ethics
100% Supplier Code of Conduct sign-off
100% sites certified to ISO 27001
Find our ESG Report to learn more about our sustainability progress.

Learn more about policies, codes, guidelines and commitments that guide our ESG practices.

Please contact us at ESG@genscript.com if you have any questions about our ESG reports or initiatives.